ArticleThe Journal of biological chemistry2020

Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells.

Ian M McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.